NDC 0143-9876-01 - Cefoxitin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0143-9876
- Requested NDC
- 0143-9876-01
- Package NDCs from labels
- 0143-9876-01, 0143-9876-10
- Manufacturer
- Hikma Pharmaceuticals USA Inc. | HIKMA FARMACEUTICA (PORTUGAL), S.A
- Effective date
- 2025-03-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Cefoxitin - Hikma Pharmaceuticals USA Inc. | HIKMA FARMACEUTICA (PORTUGAL), S.A | Hikma Pharmaceuticals USA Inc. | HIKMA FARMACEUTICA (PORTUGAL), S.A | 2025-03-03 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0143-9876-10 | 2021-01-09 | C162847 | 48780-1 | 956f9ecf-d314-621f-e053-dbdaa90a74ad | CEFOXITIN FOR INJECTION, USP |
| 0143-9876-10 | 2019-10-21 | C162847 | 48780-1 | 956f9ecf-d314-621f-e053-dbdaa90a74ad | CEFOXITIN FOR INJECTION, USP |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0143-9876-01 | Cefoxitin | 1 in 1 BOTTLE | INJECTION, POWDER, FOR SOLUTION | 1 | 13 | |
| 0143-9876-10 | Cefoxitin | 10 in 1 CARTON | INJECTION, POWDER, FOR SOLUTION | 10 | 13 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0143-9876-10 | EA - Each | 0143-9876 | b117093c-dbb7-4e2d-8252-be614fa260e2 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| CEFOXITIN SODIUM | ACTIVE INGREDIENT | Q68050H03T | CEFOXITIN INJECTION, POWDER, FOR SOLUTION [WEST-WARD PHARMACEUTICAL CORP] | 2 | |
| CEFOXITIN | ACTIVE MOIETY | 6OEV9DX57Y | CEFOXITIN INJECTION, POWDER, FOR SOLUTION [WEST-WARD PHARMACEUTICAL CORP] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cefoxitin | CEFOXITIN | WG Critical Care, LLC | 658a0dc6-6da5-44dc-94f2-1211619297f7 | 2026-08-24 | Warnings, Adverse reactions | Q68050H03T |
| Cefoxitin | CEFOXITIN | WG Critical Care, LLC | 91ac4c14-8dd8-4efe-a462-d1c488a6184f | 2025-11-12 | Warnings, Adverse reactions | Q68050H03T |
| Cefoxitin | CEFOXITIN | Hikma Pharmaceuticals USA Inc. | 6a4a2afa-4f00-41d4-bd6d-baa0a95f6929 | 2025-03-03 | Warnings, Adverse reactions | ANDA065239 0143-9876-10 0143-9876-01 0143-9876 00143987601 309072 3de36693-e566-4f2a-b9fe-8b777b275fa4 6a4a2afa-4f00-41d4-bd6d-baa0a95f6929 Q68050H03T |
| Cefoxitin | CEFOXITIN | Hikma Pharmaceuticals USA Inc. | d2c449b9-5624-4166-95b1-d7813b3d0445 | 2024-04-11 | Warnings, Adverse reactions | Q68050H03T |
| Cefoxitin | CEFOXITIN | Sagent Pharmaceuticals | b272ef9c-4d83-4ee2-b9cc-477440822cca | 2024-01-03 | Warnings, Adverse reactions | Q68050H03T |
| Cefoxitin | CEFOXITIN | WG Critical Care, LLC | f5288962-caee-4771-8229-df9cdefcfa67 | 2023-10-16 | Boxed warning, Warnings, Adverse reactions | 309072 Q68050H03T |
| Cefoxitin | CEFOXITIN SODIUM | Fresenius Kabi USA, LLC | 2a9d1e7b-96ee-4e6c-a1e8-47b76b924422 | 2023-07-10 | Warnings, Adverse reactions | Q68050H03T |
| Cefoxitin | CEFOXITIN SODIUM | Fresenius Kabi USA, LLC | d02170ff-65aa-48b8-a922-94271c46ffa7 | 2022-09-23 | Warnings, Adverse reactions | Q68050H03T |
| Cefoxitin | CEFOXITIN | SAMSON MEDICAL TECHNOLOGIES LLC | ea6dba56-5d9c-463a-b1d9-f7af5b602ed9 | 2020-11-16 | Boxed warning, Warnings, Adverse reactions | Q68050H03T |
| Cefoxitin | CEFOXITIN | Sagent Pharmaceuticals | 4c6f7665-204f-6c69-7669-61204d756e6e | 2020-06-09 | Boxed warning, Warnings, Adverse reactions | 309072 Q68050H03T |
| Cefoxitin and Dextrose | CEFOXITIN SODIUM | B. Braun Medical Inc. | 6c7e9485-1ede-411c-8c46-911439332864 | 2019-07-29 | Warnings, Adverse reactions | Q68050H03T |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.